Furthermore, USP49 increased sensitivity to gemcitabine and inhibited proliferation in cancer cells via stabilizing FK506-binding protein 51 (FKBP51) expression, which in turn negatively mediated AKT activation (51). Here, AKT1 is linked to cancer.